Opposing regulation of interleukin-8 and NF-kB responses by lipoxin A4 and serum amyloid a via the common lipoxin a receptor

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 2, 2004, Pages 145-155

  Sodin Semrl, S ^a   Spagnolo, A ^a   Mikus, R ^a   Barbaro, B ^a   Varga, J ^a   Fiore, Stefano ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Acute phase reactants; Cytokines; Inflammation; Lipid mediators; Transcription factors

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; G PROTEIN COUPLED RECEPTOR; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIGAND; LIPOXIN A; LIPOXIN A RECEPTOR; SERUM AMYLOID A; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ARTHROPATHY; ARTICLE; CHO CELL; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; FIBROBLAST LIKE SYNOVIOCYTE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IL 8 GENE; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNOVIOCYTE; UPREGULATION;

EID: 9644303534     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700206     Document Type: Article

References (56)

1. rd. 2002. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J. Rheumatol. 65(S):3.
2. Migita K., S. Honda, S. Yamasaki, Y. Hirai, T. Fukuda, T. Aoyagi, M. Kita, H. Ida, T. Tsukada, A. Kawakami, Y. Kawabe and K. Eguchi. 2000. Regulation of rheumatoid synovial cell growth by ceramide. Biochem. Biophys. Res. Commun. 269:70.
3. Konttinen Y.T., T-F. Li, M. Hukkanen, J. Ma, J-W. Xu and I. Virtanen. 2000. Fibroblast biology. Signals targeting the synovial fibroblast in arthritis. Arthritis Res. 2:348.
4. Kawanaka N., M. Yamamura, T. Aita, Y. Morita, A. Okamoto, M. Kawashima, M. Iwahashi, A. Ueno, Y. Ohmoto and H. Makino. 2002. CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 46:2578.
5. Bischof R.J., D. Zafiropoulos, J.A. Hamilton and I.K. Campbell. 2000. Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin. Exp. Immunol. 119:361.
6. Woolley D.E. and L.C. Tetlow. 2000. Mastcellactivation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res. 2:5.
7. Yamamura Y., R. Gupta, Y. Morita, X. He, R. Pai, J. Endres, A. Freiberg, K. Chung and D.A. Fox. 2001. Effector function of resting T cells: activation of synovial fibroblasts. J. Immunol. 166:2270.
8. Maini R.N., C. Plater-Zyberk and E. Andrew. 1987. Autoimmunity in rheumatoid arthritis. An approach via a study of B lymphocytes. Rheum. Dis. Clin. North Am. 2:319.
9. Firestein G.S. 1996. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Rheum. Arthritis 39:1781.
10. Yamanishi Y. and G.S. Firestein. 2001. Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum. Dis. Clin. North Am. 2:355.
11. Georganas C., H. Liu, H. Perlman, A. Hoffmann, B. Thimmapaya and R.M. Pope. 2000. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: dominant role for NF-kB but not C/EBP or c-Jun. J. Immunol.165:7199.
12. Feldmann M. 2001. Pathogenesis of arthritis: recent research progress. Nat. Immunol. 2:771.
13. Mukaida N., A. Harada, K. Yasumoto and K. Matsushima. 1992. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol. Immunol. 36:773.
14. Gillitzer R., U. Ritter, U. Spandau, M. Goebeler and E.B. Brocker. 1996. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J. Invest. Dermatol. 107:778.
15. Marok R., P.G. Winyard, A. Coumbe, M.L. Kus, K. Gaffney, S. Blades, P.I. Mapp, C.J. Morris, D.R. Blake, C. Kaltschmidt and P.A. Baeuerle. 1996. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum. 39:583.
16. Han Z., L. Chang, Y. Yamanishi, M. Karin and G.S. Firestein. 2002. Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murinecollagen-induced arthritis. Arthritis Rheum. 46:818.
17. Han Z., D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A.M. Manning and G.S. Firestein. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108:13.
18. Karin M. and M. Delhase. 2000. The 1B kinase (IKK) and NF-κB: key elements of proinflammatory signalling. Semin. Immunol. 12:85.
19. Han Z., D.L. Boyle, AM. Manning and G.S. Firestein. 1998. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28:197.
20. Tsai C., L.A. Diaz, Jr., N.G. Singer, L.L. Li, A.H. Kirsch, R. Mitra, B.J. Nickoloff, L.J. Crofford and D.A. Fox. 1996. Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. Arthritis Rheum. 39:125.
21. Pierce J.W., R. Schoenleber, G. Jesmok, J. Best, S.A. Moore, T. Collins and M.E. Gerritsen. 1997. Novel inhibitors of cytokine-induced 1kappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:21096.
22. Isomaki P. and J. Punnonen. 1997. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann. Med. 29:499.
23. Alaaeddine N., J.A. Di Battista, J.P. Pelletier, K. Kiansa, J.M. Cloutier and J. Martel- Pelletier. 1999. Differential effects of 1L-8, LlF (pro-inflammatory) and IL-II (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblast. Cylokine 11:1020.
24. Serhan C.N. and N. Chiang. 2002. Lipid-derived mediators in endogenous anti-inflammation and resolution: Lipoxins and aspirin-triggered 15-epi-Lipoxins. Scientific World Journal. 2:169.
25. Serhan C.N. 2002. Lipoxins and aspirin triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat. 68:433.
26. Takano T., S. Fiore, J.F. Maddox, H.R. Brady, N.A. Petasis and C.N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors. J. Exp. Med. 185:1693.
27. Clish C.B., J.A. O'Brien, K. Gronert, G.L. Stahl, N.A. Petasis and C.N. Serhan. 1999. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. U S A 96:8247.
28. Sodin-Semrl S., B. Taddeo, D. Tseng, J. Varga and S. Fiore. 2000. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164:2660.
29. Fiore S., S. Sodin-Semrl, Y. Rang and J. Varga. 2000. Activation of LXA4R or serum amyloid A results in opposite regulation of NF-kB DNA binding in human synovial fibroblasts. Arthritis Rheum. 43:S158.
30. Devchand P.R., M. Arita, S. Hong, G. Bannenberg, R.L. Mousignac, K. Gronert and C.N. Serhan. 2003. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 17:652.
31. a nalogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J. Immunol. 168:5260.
32. Furlaneto CJ. and A. Campa. 2000. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 268:405.
33. He R., H. Sang and R.D. Ye. 2003. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LX A4R. Blood 101:1572.
34. Patel H., R. Fellowes, S. Coade and P. Woo. 1998. Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 48:410.
35. Cunnane G., S. Grehan, S. Geoghegan, C. McCormack, D. Shields, A.S. Whitehead, B. Bresnihan and O. Fitzgerald. 2000. Serum amyloid A in the assessment of early inflammatory arthritis. J. Rheumatol. 27:58.
36. Uhlar C.M. and A.S. Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265:501.
37. Yap S.H., H.J. Moshage, B.P. Hazenberg, H.M. Roelofs, J. Bijzet, P.C. Limburg, L.A. Aarden and M.H. van Rijswijk. 1991. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary culturesof human hepatocytes. Biochim. Biophys. Acta 1091:405.
38. Kalmovarin N., W.E. Friedrichs, H.V. O'Brien, L.A. Linehan, B.H. Bowman and F. Yang. 1991. Extrahepatic expression of plasma protein genes during inflammation. Inflamm. 15:369.
39. Su S.B., W. Gong, J.L. Gao, W. Shen, P.M. Murphy, J.J. Oppenheim and J.M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:395.
40. Fiore S. and C.N. Serhan. 1995. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochem. 34:16678.
41. Jung Y.D., F. Fan, D.J. McConkey, M.E. Jean, W. Liu, N. Reinmuth, O. Stoeltzing, S.A. Ahmad, A.A. Parikh, N. Mukaida and L.M. Ellis. 2002. Role of P38 MAPK, AP-1, and NF-kappaB in interleukin-1beta-induced IL-8 expression in human vascular smooth muscle cells. Cytokine 18:206.
42. Fiore S., J.F. Maddox, H.D. Ferez and C.N. Serhan. 1994. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180:253.
43. Fiore S., S.W. Ryeom, P.F. Weller and C.N. Serhan. 1992. Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. J. of Biol. Chem. 267:16168.
44. Fierro I.M. and C.N. Serhan. 2001. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. Braz. J. of Med. and Biol. Res. 34:555.
45. Mitchell S., G. Thomas, K. Harvey, D. Cottell, k. Reville, G. Berlasconi, N.A. Petasis, L. Erwig, A.J. Rees, J. Savill, H.R. Brady and C. Godson. 2002. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol. 13:2497.
46. 4. J. Pharmacol Exp. Therap. 300:385.
47. McMahon B., D. Mitchell, R. Shattock, F. Martin, H.R. Brady and C. Godson. 2002. Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J. 16:1817.
48. Serhan C.N. 1997. Lipoxins and novel aspirin-triggered 15 epi-lipoxins (ATL): jungle of cell-cell interactions or therapeutic opportunity? Prostaglandins 53:107.
49. Chiang N., I.M. Fierro, K. Gronert, and C.N. Serhan. 2000. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191:1197.
50. Resnati M., I. Pallavicini, J.M. Wang, J. Oppenheim, C.N. Serhan, M. Romano and F. Blasi. 2002. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Nat. Acad. Sci. of U S A 99:1359.
51. Perretti M., N. Chiang, M. La, I.M. Fierro, S. Marullo, S.J. Getting, E. Solito and C.N. Serhan. 2002. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor. Nat. Med. 8:1296.
52. Migita K., Y. Kawabe, M. Tominaga, T. Origuchi, T. Aoyagiand K. Eguchi. 1998. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab. Invest. 78:535.
53. Mitchell T.I, J.J. Jeffrey, R.D. Palmiter and C.E. Brinckerhoff. 1993. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim. Biophys. Acta 1156:245.
54. Ray A. and B.K. Ray. 1999. Persistent expression of serum amyloid A during experimentally induced chronic inflammatory condition in rabbit involves differential activation of SAF, NF-kappa B, and C/EBP transcription factors. J. Immunol. 163:2143.
55. Li X.X. and W.S. Liao. 1991. Expression of rat serum amyloid A1 gene involves both C/EBP-like and NF kappa B-like transcription factors. J. Biol. Chem. 266:15192.
56. Iguchi A., I. Kitajima, M. Yamakuchi, S. Ueno, T. Aikou, T. Kubo, K. Matsushima, N. Mukaida and I. Maruyama. 2000. PEA3 and AP-1 are required for constitutive IL-8 gene expression in hepatoma cells. Biochem. Biophys. Res. Commun. 279:166.